Clinical trial
Clinical Post- Approval Study of the Neuspera Sacral Neuromodulation (SNM) System in Patients With Symptoms of Urinary Urgency Incontinence (UUI)
NCT07144813 is registered in ClinicalTrials.gov with Neuspera Medical, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Post- Approval Study of the Neuspera Sacral Neuromodulation (SNM) System in Patients With Symptoms of Urinary Urgency Incontinence (UUI)
- Lead sponsor
- Neuspera Medical, Inc.
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- September 3, 2025
- Completion date
- December 31, 2029
- Enrollment
- 116 (estimated)
- Sites
- 20
Conditions
As the registry lists them; a condition with its own page is linked.
urinary urgency incontinence